2024 연구자 정보 (19 / 1073)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Chen, Li-Tzong (Chen, LT) |
Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc Res, Kaohsiung, Taiwan Natl Cheng Kung Univ Hosp, Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Cho, Kanghee (Cho, KH) |
Inha Univ, Dept Chem & Chem Engn, Incheon 22212, South Korea |
|
|
[JCR상위 1.0%] Biomass-derived materials for energy storage and electrocatalysis: recent advances and future perspectives | SCIE | 1.0 |
ENVIRONMENTAL SCIENCES SOIL SCIENCE |
catalica@uos.ac.kr namhs219@knu.ac.kr dylee82@hanbat.ac.kr |
||
|
Chung, Hyun Cheol (Chung, HC) |
Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea |
AFB-8969-2022 Chung, Hyun Cheol |
0000-0002-0920-9471 Chung, Hyun |
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Cloutier, Daniel (Cloutier, D) |
Vir Biotechnol, San Francisco, CA USA |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Fukushima, Norimasa (Fukushima, N) |
Yamagata Prefectural Cent Hosp, Dept Surg, Yamagata, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Gane, Edward (Gane, E) |
Univ Auckland, Dept Med & Hlth Sci, Auckland, New Zealand |
AGN-7071-2022 Gane, Edward |
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Gupta, Sneha, V (Gupta, S) |
Vir Biotechnol, San Francisco, CA USA |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Hagihara, Shunsuke (Hagihara, S) |
China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Hirashima, Yoshinori (Hirashima, Y) |
Ono Pharmaceut, Osaka, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Hwang, Carey (Hwang, C) |
Vir Biotechnol, San Francisco, CA USA |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Jeon, Hyerim (Jeon, H) |
제1저자 | Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 37224, South Korea |
|
|
[JCR상위 1.0%] Military Non-Terrestrial Networks Architecture and Spectrum Sharing Method for Mitigating Jamming Attacks and Multiple Access Interference | SCIE | 1.0 |
ENGINEERING, ELECTRICAL & ELECTRONIC TELECOMMUNICATIONS |
jhr020528@knu.ac.kr neloyou@knu.ac.kr |
|
|
Ji, Jiafu (Ji, JF) |
Beijing Canc Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Kim, B. N. (Kim, BN) |
제1저자 |
Pusan Natl Univ, Finance Fishery Manufacture Ind Math Ctr Big Data, Busan 46241, South Korea Kyung Hee Univ, Dept Appl Math, Yongin 17104, Gyeonggi Do, South Korea |
|
|
[JCR상위 1.0%] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19 | SCIE | 1.0 | MATHEMATICS, APPLIED | sangil.kim@pusan.ac.kr | |
|
Kim, H. K. (Kim, HK) |
Hannam Univ, Dept Math Educ, Daejeon 34430, South Korea UCLA, Dept Phys & Astron, Los Angeles, CA 90095 USA |
|
|
[JCR상위 1.0%] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19 [JCR상위 23.2%] A GMRT 610 MHz radio survey of the North Ecliptic Pole (NEP, ADF-N) / Euclid Deep Field North |
SCIE | 1.0 |
MATHEMATICS, APPLIED ASTRONOMY & ASTROPHYSICS |
sangil.kim@pusan.ac.kr glenn.white@open.ac.uk |
||
|
Kim, S. (Kim, S) |
교신저자 |
Pusan Natl Univ, Inst Math Sci, Busan 46241, South Korea Pusan Natl Univ, Dept Math, Busan 46241, South Korea Pusan Natl Univ, Inst Future Earth, Busan 46241, South Korea Chosun Univ, Coll Med, Gwangju, South Korea Univ Seoul, Seoul, South Korea |
|
|
[JCR상위 1.0%] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19 [JCR상위 6.0%] Nrf2 activation attenuates diabetic kidney disease in preclinical in vitro and in vivo mouse model [JCR상위 24.2%] Measurement of the background in the CMS muon detector in pp-collisions at √s=13 TeV |
SCIE | 1.0 |
MATHEMATICS, APPLIED ENDOCRINOLOGY & METABOLISM PHYSICS, PARTICLES & FIELDS |
sangil.kim@pusan.ac.kr piet.verwilligen@cern.ch |
페이지 이동: